NRG
MRK icon

Nemes Rush Group’s Merck MRK Stock Holding History

Nemes Rush Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.6M Sell
170,964
-11,111
-6% -$1.28M 1.95% 13
2025
Q4 		$19.2M Sell
182,075
-2,395
-1% -$225K 1.8% 14
2025
Q3 		$15.5M Buy
184,470
+1,672
+0.9% +$138K 1.53% 20
2025
Q2 		$14.5M Buy
182,798
+48,372
+36% +$3.85M 1.58% 20
2025
Q1 		$12.1M Buy
134,426
+8,587
+7% +$802K 1.52% 21
2024
Q4 		$12.5M Sell
125,839
-5,152
-4% -$531K 1.55% 18
2024
Q3 		$17.3M Sell
130,991
-6,405
-5% -$761K 2.51% 8
2024
Q2 		$17M Buy
137,396
+4,960
+4% +$639K 2.34% 10
2024
Q1 		$17.5M Buy
132,436
+12,742
+11% +$1.57M 2.5% 8
2023
Q4 		$13M Buy
119,694
+2,644
+2% +$274K 2.1% 8
2023
Q3 		$12.1M Buy
117,050
+3,002
+3% +$324K 2.18% 10
2023
Q2 		$13.2M Buy
+114,048
New +$12.9M 2.32% 9

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nemes Rush Group's MRK Position: Q1 2026 in Review

Nemes Rush Group reduced its Merck (MRK) stake by 6.1% in Q1 2026, selling an estimated $1.28M and leaving 170,964 shares worth $20.6M. The position accounts for 1.95% of the portfolio, ranked #13.

Nemes Rush Group first reported a position in MRK in Q2 2023 and has held it in 12 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Nemes Rush Group held 170,964 shares of Merck worth $20.6M as of Q1 2026.
  • Nemes Rush Group sold 11,111 Merck shares in Q1 2026, an estimated $1.28M.
  • Merck made up 1.95% of Nemes Rush Group's portfolio in Q1 2026, its #13 holding.
  • Nemes Rush Group first reported a position in Merck in Q2 2023 and has held it in 12 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.